News
-
-
-
-
-
-
-
PRESS RELEASE
Integrated BioPharma Reports Results for its Quarter Ended March 31, 2024
Integrated BioPharma, Inc. reports financial results for Q1 2024, showing stable revenue and net income compared to Q1 2023. The company aims to reduce reliance on key customers. Details and future outlook provided -
-
PRESS RELEASE
Edesa Biotech Reports Fiscal 2nd Quarter 2024 Results
Edesa Biotech, Inc. reported financial results for the three and six months ended March 31, 2024, focusing on its Phase 3 ARDS study, EB05 drug candidate, and strategic plans for respiratory technology and dermatology. The company showcased operational efficiency and prudent capital management -
PRESS RELEASE
Siyata Mobile Announces Closing of Approximately $4.0 Million Public Offering of Common Shares and Pre-Funded Warrants
Siyata Mobile Inc. closes $4.0 million public offering of common shares and pre-funded warrants at $1.30/share. Funds for growth, marketing, and potential acquisitions